Genomic Fate Maps

基因组命运图谱

基本信息

  • 批准号:
    8215841
  • 负责人:
  • 金额:
    $ 32.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-02-01 至 2015-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Recent, surprising, and controversial discoveries have challenged conventional concepts regarding the origins and plasticity of stem cells, and their contributions to tissue regeneration, and highlight just how little is known about mammalian development in comparison to simpler model organisms. In the case of the transparent worm, C. elegans, Sulston and colleagues used a microscope to record the birth and death of every cell during its life, and the compilation of this fate maps represents a milestone achievement of developmental biology. Determining a fate map for mammals or other higher organisms is more complicated, because they are opaque, take a long time to mature, and have a tremendous number of cells. Consequently, fate mapping experiments have relied on tagging a progenitor cell with a dye or genetic marker in order to later identify its descendants. This approach, however, extracts little information, because it only reveals that a population of cells, all inheriting the same label, share a common ancestor but tells nothing of how each cell is related to one another. To avoid that, as well as the technical limitations of current methods for mapping cell fate, we propose a new strategy for retrospectively deriving cell fate maps by using phylogenetics to infer the order in which somatic mutations have arisen in the genomes of individual cells during the development of multicellular organisms. DNA replication introduces mutations, particularly at repetitive sequences, every time a cell divides. In Preliminary Studies we demonstrate that cataloging the frequent mutations affecting the length of polyguanine tracts allows for deducing the history of mouse cells either passaged in culture or sampled from the various tissues of a single individual. Toward an ultimate goal of constructing a high resolution mammalian cell fate map, we plan three Specific Aims: 1. Compare phylogenetic fate maps to conventional fate maps derived from genetically marked mice. 2. Advance the technology of this approach. 3. Successively build a liver cell fate map in order to address controversies regarding the clonal, embryonic, and anatomic origins of hepatic stem cells during development and in disease.A goal of biology is to understand how a single cell divides and gives rise to all the different tissues and organs in the body. Fate maps describe how cells within an individual are related to one another and can be likened to a tree of life, in which the origin of a particular cell can be traced back through its progenitors to the fertilized egg. We propose a new method for exploring developmental biology by constructing fate maps based on distinctive mutations inevitably accumulating in the genome each time a cell divides. We will initially focus our studies on how the liver develops and responds to injury.
描述(由申请人提供):最近,令人惊讶的和有争议的发现已经挑战了关于干细胞的起源和可塑性及其对组织再生的贡献的传统概念,并突出了与更简单的模型生物体相比,对哺乳动物发育的了解是多么少。在透明蠕虫的情况下,C. Sulston及其同事使用显微镜记录了每个细胞在其生命过程中的出生和死亡,这一命运图的编制代表了发育生物学的里程碑式成就。确定哺乳动物或其他高等生物的命运图更为复杂,因为它们是不透明的,需要很长时间才能成熟,并且有大量的细胞。因此,命运定位实验依赖于用染料或遗传标记标记祖细胞,以便以后识别其后代。然而,这种方法提取的信息很少,因为它只揭示了一个细胞群体,所有继承相同的标签,共享一个共同的祖先,但没有告诉每个细胞是如何相互关联的。为了避免这一点,以及目前绘制细胞命运的方法的技术局限性,我们提出了一种新的策略,通过使用多细胞遗传学来推断在多细胞生物的发育过程中个体细胞的基因组中体细胞突变出现的顺序,来回顾性地推导细胞命运图。每当细胞分裂时,DNA复制都会引入突变,特别是在重复序列上。在初步研究中,我们证明,编目的频繁突变影响的长度的聚鸟嘌呤束允许推导的历史,小鼠细胞在培养中传代或从一个单一的个人的各种组织取样。为了构建一个高分辨率的哺乳动物细胞命运图的最终目标,我们计划了三个具体目标:1。比较系统发育的命运地图传统的命运地图来自遗传标记的小鼠。2.推进这种方法的技术。3.成功地建立了肝细胞命运图,以解决有关肝干细胞在发育和疾病中的克隆,胚胎和解剖起源的争议。生物学的目标是了解单个细胞如何分裂并产生体内所有不同的组织和器官。命运图描述了一个人体内的细胞是如何相互关联的,可以比作一棵生命之树,其中特定细胞的起源可以通过其祖细胞追溯到受精卵。我们提出了一种探索发育生物学的新方法,即根据细胞每次分裂时不可避免地在基因组中积累的独特突变构建命运图。我们最初将重点研究肝脏如何发育和对损伤的反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARSHALL S. HORWITZ其他文献

MARSHALL S. HORWITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARSHALL S. HORWITZ', 18)}}的其他基金

Pathogenesis of ELANE-Associated Neutropenia
ELANE 相关中性粒细胞减少症的发病机制
  • 批准号:
    9011147
  • 财政年份:
    2016
  • 资助金额:
    $ 32.49万
  • 项目类别:
Genomic Fate Maps
基因组命运图谱
  • 批准号:
    7994875
  • 财政年份:
    2010
  • 资助金额:
    $ 32.49万
  • 项目类别:
Genomic Fate Maps
基因组命运图谱
  • 批准号:
    8050657
  • 财政年份:
    2008
  • 资助金额:
    $ 32.49万
  • 项目类别:
Genomic Fate Maps
基因组命运图谱
  • 批准号:
    7760668
  • 财政年份:
    2008
  • 资助金额:
    $ 32.49万
  • 项目类别:
Genomic Fate Maps
基因组命运图谱
  • 批准号:
    7560995
  • 财政年份:
    2008
  • 资助金额:
    $ 32.49万
  • 项目类别:
NIH Director's Pioneer Award
NIH 院长先锋奖
  • 批准号:
    7672396
  • 财政年份:
    2007
  • 资助金额:
    $ 32.49万
  • 项目类别:
NIH Director's Pioneer Award
NIH 院长先锋奖
  • 批准号:
    7340789
  • 财政年份:
    2007
  • 资助金额:
    $ 32.49万
  • 项目类别:
NIH Director's Pioneer Award
NIH 院长先锋奖
  • 批准号:
    7919259
  • 财政年份:
    2007
  • 资助金额:
    $ 32.49万
  • 项目类别:
NIH Director's Pioneer Award
NIH 院长先锋奖
  • 批准号:
    8128696
  • 财政年份:
    2007
  • 资助金额:
    $ 32.49万
  • 项目类别:
Mistargeting of Elastase in Bone Marrow Failure
骨髓衰竭中弹性蛋白酶的误定位
  • 批准号:
    7105072
  • 财政年份:
    2004
  • 资助金额:
    $ 32.49万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.49万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了